Mersana Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Mersana Therapeutics, Inc. Website Screenshot

http://www.mersana.com

Mersana Therapeutics, Inc. Company Intro

Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication.  As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]

Industry

Healthcare

Mersana Therapeutics, Inc. Headquaters

840 Memorial Drive
Cambridge,02139
United States


Mersana Therapeutics, Inc. Share price

23 Oct 2020 02:06 GMT

$17.92

0.03 (0.17 %)


Mersana Therapeutics, Inc. Market cap

$1.273 B


WMC RANKING

2020

Mersana Therapeutics, Inc. # 219

Biotechnology



Latest Mersana Therapeutics, Inc. News

News 23 Oct 2020

Mersana Therapeutics Inc. (MRSN): Skating on Thin Ice? We ...

Mersana Therapeutics Inc. (NASDAQ:MRSN) went up by 3.97% from its latest closing price compared to the recent 1-year high of $26.64. The company's stock ...

News 23 Oct 2020

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Stock Jumped ...

In last trading session, Mersana Therapeutics, Inc. (NASDAQ:MRSN) saw 1,605,756 shares changing hands with its beta currently measuring 2.38. Company's ...

News 23 Oct 2020

Mersana Therapeutics Inc. (MRSN) last month performance of ...

Mersana Therapeutics Inc. (NASDAQ: MRSN) open the trading on October 22, 2020, with great promise as it jumped 3.97% to $18.60. During the day, the stock ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Mersana Therapeutics, Inc. 0.03 1.63 2.17 0 0 0 3.36
Alexion Pharmaceuticals, Inc. 100 13.22 100 0 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.11 0 0 0 91.95
3SBio Inc. 96.05 0 0 0 0 0 0
Incyte Corporation 40.27 14.26 7.25 0 0 0 18.99

Mersana Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Mersana Therapeutics, Inc. $1,693 $72,517 $-69,750 $1.273B 219
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.228B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $54.719B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.699B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.79B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

A free one-on-one demo with one of our team and see exactly what the WMC business intelligence platform can do for your organisation.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries